Carregant...

The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection

Dengue has a major impact on global public health, and the use of dengue vaccine is very limited. In this study, we evaluated the immunogenicity and protective efficacy of a dengue vaccine made from a recombinant measles virus (MV) that expresses envelope protein domain III (ED3) of dengue-1 to 4. F...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Hu, Hui-Mei, Chen, Hsin-Wei, Hsiao, Yu-Ju, Wu, Szu-Hsien, Chung, Han-Hsuan, Hsieh, Chun-Hsiang, Chong, Pele, Leng, Chih-Hsiang, Pan, Chien-Hsiung
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964840/
https://ncbi.nlm.nih.gov/pubmed/26901482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1143576
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!